Guidelines

A-121 PHARMACOKINETIC RESULTS OF TWO STUDIES WITH A NEW FIBRINOGEN CONCENTRATE IN SUBJECTS WITH AFIBRINOGENAEMIA

February 2017
A-126 PLATELET ACETYL-COA CARBOXYLASE PHOSPHORYLATION: A POTENTIAL MARKER FOR ATHEROTHROMBOTIC CORONARY ARTERY DISEASE

February 2017
A-128 PREVALENCE OF HETEROZYGOUS TYPE 2N VON WILLEBRAND DISEASE MUTATIONS IN BELGIUM

February 2017
A-113 PREVENTABILITY OF SERIOUS ADVERSE DRUG REACTIONS RELATED TO THE USE OF DIRECT ORAL ANTICOAGULANTS: A PROSPECTIVE STUDY

February 2017
A-120 THE IMPORTANCE OF A LOW LIMIT OF DETECTION FOR COAGULATION FACTOR ASSAYS: FIX, AN EXAMPLE IN DAILY PRACTICE

February 2017
A-133 ACQUIRED HAEMOPHILIA A

February 2017
A-129 SUSTAINED INHIBITION OF ACETYL-COA CARBOXYLASE DECREASES PLATELET DENSE GRANULES SECRETION AND AGGREGATION

February 2017
A-132 PEAR1 PROMOTER METHYLATION IS ASSOCIATED WITH PLATELET AND WHITE BLOOD CELL PHENOTYPES IN THE MOLI-FAMILY COHORT

February 2017
A-123 P2X1 ION CHANNEL IS CRITICAL FOR VASCULAR INTEGRITY IN INFLAMMATION

February 2017
A-134 ITPKB AS NEW PLATELET-ACTIVATION REGULATOR

February 2017

Top